Table 3 Multivariate analysis of non-relapse mortality, relapse, and engraftment
Endpoints of the study | HR (95% CI) | P |
|---|---|---|
NRM | ||
Variables | ||
Conditioning | 0.692(0.310–1.545) | 0.369 |
Age of recipient | 1.019(0.975–1.065) | 0.396 |
Disease status at BMT | 1.639(0.775–3.469) | 0.196 |
Ph chromosome status | 0.808(0.329–1.984) | 0.641 |
CD34 dose | 1.008(0.917–1.108) | 0.873 |
Comorbidities | 1.380(0.512–3.721) | 0.524 |
Diagnosis to transplant lag period | 1.005(0.989–1.023) | 0.531 |
Relapse | ||
Variables | ||
Conditioning (TBI/Cy versus Bu/Cy) | 2.709(1.106–6.638) | 0.029 |
Age of recipient | 0.977(0.914–1.045) | 0.500 |
Philadelphia chromosome status | 0.1321(0.437–3.995) | 0.622 |
Engraftment | ||
Variables | ||
Conditioning (TBI/Cy versus Bu/Cy) | 1.229(0.809–1.868) | 0.333 |
Disease status at BMT | 1.085(0.774–1.521) | 0.635 |
CD34 dose | 0.999(0.942–1.059) | 0.970 |